Indication
Essential HTN in adults, childn & adolescents 6-18 yr. Renal disease in adult patients w/ HTN & type 2 DM w/ proteinuria ≥0.5 g/day as part of antihypertensive treatment. CHF in adult patients to whom ACE inhibitor is not suitable due to incompatibility, cough & contraindication. Reduction in risk of stroke in hypertensive adults w/ left ventricular hypertrophy documented by ECG.